Regulatory

The Council for Responsible Nutrition wrote to FDA on May 4 urging the agency to consider all of the safety evidence for CBD supplements that supplement companies have so far submitted to the agency.

Australia’s Therapeutic Goods Administration (TGA) has added galactooligosaccharides (GOS) to its Permissible Ingredients Determination for listed complementary medicines in Australia, announced GOS ingredient supplier FrieslandCampina Ingredients.

The Council for Responsible Nutrition’s citizen petition asks FDA to “reconsider” how the agency has been invoking the FD&C Act’s drug preclusion clause to remove dietary supplement ingredients from the market.

The company says D-BHB can increase levels of blood ketones without requiring users to consume excess calories and fat associated with a typical low-carb diet.

Setria glutathione is an antioxidant ingredient that has been shown to support the immune system and overall health and wellness, the firm says.

Representative Jeff Duncan, a republican congressman representing South Carolina’s 3rd District, has sent a letter to the U.S. Food and Drug Administration’s Commissioner, Robert M. Califf, MD, asking the Agency to hold public hearing on NMN decision.

The paper summarizes the rationale for using proprietary blends in dietary supplements, how they are regulated and labeled, as well as the challenges this presents for researchers.

Industry advocates defend the safety record of melatonin and criticize the letter as misleading and ill-informed.

The review raises concerns about the potential toxicity of CBD but industry advocates contend that the research is misleading and outside of the scope of dietary supplement products.

Two identical bills have been introduced to the New York State Assembly (A05610-B) and Senate (S05823B) are an updated version of previous bills (S-16/A431) vetoed by Governor Kathy Hochul in January of 2023.

Steve Mister, president and CEO of CRN sits down with Nutritional Outlook at SupplySide East to discuss the recent Ipsos survey the group commissioned with CHPA, as well as other regulatory updates.

CITES is an international agreement between governments to ensure that international trade involving wild animals and plants is conducted in a way that does not threaten the survival of animal and plant species.

HP Ingredients has announced an independent conclusion of GRAS (generally recognized as safe) for its Bergamonte bergamot extract.

According to Nutrasource, this is the first time that a supplement manufactured in South Korea will bear the IFOS label without having to import ingredients or be manufactured outside the country.

NOW is asking Amazon to recall the products, which fraudulently claim to be from NOW itself as well as from another unnamed leading supplement brand.

The Federal Trade Commission has issued a Notice of Penalty Offenses Concerning Substantiation of Product Claims to hundreds of brands, putting them on notice about the civil penalties that could result from making unsubstantiated claims on its products.

The ingredient has already garnered regulatory nods ranging from self-substantiated claims under Food Standards Australia New Zealand, approval from the Food & Drug Administration Philippines, and structure-function claims in the U.S.

Celebs and influencers can bring in sales, but working with them may pose regulatory risks.

Last year, the EU introduced new regulations for infant and follow-on formulas manufactured with protein hydrolysates.

Here’s how to stay in the safe zone.

CV Sciences Inc. (San Diego, CA) has received a formal Certificate of Grant from the Japanese Patent Office (JPO) for its patent application 7216697.

A Colorado Senate Bill (SB 23-176) titled “Protections For People With An Eating Disorder” has been amended to remove restrictions to the sale of dietary supplements marketed for weight management.

Kentucky Governor Andy Beshear has signed House Bill 544 into law to regulate the sale of delta-8 THC products.

Anderson Advanced Ingredients announced that it has received a “letter of no objection” from FDA in response to its GRAS (generally recognized as safe) notification for a resistant dextrin made from tapioca.

Now continues its industry self-policing program with the testing of bromelain products sold on Amazon by unfamiliar brands.

If passed, the law would prohibit the sale of delta-8 THC or any other hemp-derived substance with an intoxicating effects on consumers to those under the age of 21, while also setting standards for the production and sale of said products.

The two pieces of legislation are called the "Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023," and the "CBD Product Safety and Standardization Act of 2023."

How testing and certification give sports-nutrition brands an edge.